⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVTR News
Avantor, Inc.
$1.5 Billion AI-based Clinical Trials Market 2026-2032: Rising Investment from Biopharma Sponsors and CROs
globenewswire.com
GOOGL
INTC
IBM
AVTR
PHG
RRX
TEMP
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Investors to Inquire about Securities Investigation
accessnewswire.com
AVTR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out
accessnewswire.com
AVTR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out
accessnewswire.com
AVTR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect
accessnewswire.com
AVTR
p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor
businesswire.com
AVTR
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
AVTR
Did You Lose Money on Avantor, Inc. (AVTR)? Levi & Korsinsky Urges Investors to Act Before December 29, 2025
accessnewswire.com
AVTR
Class Action Reminder from Pomerantz LLP for Investors of Avantor, Inc. – AVTR
accessnewswire.com
AVTR
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit – AVTR
globenewswire.com
AVTR